• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

内脏肥胖及其与代谢功能障碍相关脂肪性肝病患者严重冠状动脉钙化的关联。

Visceral Obesity and Its Association with Severe Coronary Artery Calcification in Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease.

作者信息

Kang Min Kyu, Song Jeung Eun, Kweon Young Oh, Tak Won Young, Park Soo Young, Lee Yu Rim, Park Jung Gil

机构信息

Department of Internal Medicine, College of Medicine, Yeungnam University, Daegu 42415, Republic of Korea.

Department of Internal Medicine, School of Medicine, Daegu Catholic University, Daegu 42472, Republic of Korea.

出版信息

Diagnostics (Basel). 2024 Oct 17;14(20):2305. doi: 10.3390/diagnostics14202305.

DOI:10.3390/diagnostics14202305
PMID:39451628
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11506773/
Abstract

: The role of body composition parameters in patients with metabolic dysfunction-associated steatotic liver disease (MASLD) with presence and severity of coronary artery calcification (CAC) is still not fully elucidated. We aimed to evaluate the impact of computed tomography (CT)-based body composition parameters in patients with MASLD with CAC severity. : In this multicenter study, 1870 individuals underwent cardiac CT for the detection of CAC as well as ultrasonography for the diagnosis of hepatic steatosis. The presence of CAC was defined by a CAC score threshold of >0, while severe CAC was defined by a threshold of >300. Using the abdominal cross-sectional CT images at the L3 vertebra level, we analyzed the skeletal muscle index, visceral to subcutaneous adipose tissue ratio, and muscle density using the Hounsfield unit. : Of 648 patients with MASLD, the proportions of presence of CAC and severe CAC were 45.2% and 9.9%, respectively. Visceral obesity was not associated with the presence of CAC after adjustment for age, sex, smoking, statin therapy, type 2 diabetes, and advanced fibrosis (adjusted odds ratio (aOR), 1.38; 95% confidence interval (CI), 0.86-2.23; = 0.180). However, visceral obesity was independently associated with severe CAC after adjustment for several metabolic risk factors (aOR, 3.54; 95% CI, 1.25-14.90; = 0.039), and adjustment for atherosclerotic cardiovascular disease risk scores (aOR, 3.74; 95% CI, 1.31-15.79; = 0.032). : Visceral obesity may serve as a novel prognostic CT-based radiological biomarker for patients with MASLD with severe CAC.

摘要

身体成分参数在伴有冠状动脉钙化(CAC)的存在及严重程度的代谢功能障碍相关脂肪性肝病(MASLD)患者中的作用仍未完全阐明。我们旨在评估基于计算机断层扫描(CT)的身体成分参数对患有CAC严重程度的MASLD患者的影响。:在这项多中心研究中,1870名个体接受了心脏CT检查以检测CAC以及超声检查以诊断肝脂肪变性。CAC的存在由CAC评分阈值>0定义,而严重CAC由阈值>300定义。使用L3椎体水平的腹部横断面CT图像,我们使用亨氏单位分析了骨骼肌指数、内脏与皮下脂肪组织比率以及肌肉密度。:在648例MASLD患者中,CAC存在和严重CAC的比例分别为45.2%和9.9%。在校正年龄、性别、吸烟、他汀类药物治疗、2型糖尿病和晚期纤维化后,内脏肥胖与CAC的存在无关(校正比值比(aOR),1.38;95%置信区间(CI),0.86 - 2.23;P = 0.180)。然而,在校正多个代谢危险因素后,内脏肥胖与严重CAC独立相关(aOR,3.54;95%CI,1.25 - 14.90;P = 0.039),并且在校正动脉粥样硬化性心血管疾病风险评分后(aOR,3.74;95%CI,1.31 - 15.79;P = 0.032)。:内脏肥胖可能作为患有严重CAC的MASLD患者基于CT的一种新的预后放射生物标志物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0709/11506773/76895243711d/diagnostics-14-02305-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0709/11506773/03e9efab54cf/diagnostics-14-02305-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0709/11506773/7ca806f1e24e/diagnostics-14-02305-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0709/11506773/da629831b3ad/diagnostics-14-02305-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0709/11506773/76895243711d/diagnostics-14-02305-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0709/11506773/03e9efab54cf/diagnostics-14-02305-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0709/11506773/7ca806f1e24e/diagnostics-14-02305-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0709/11506773/da629831b3ad/diagnostics-14-02305-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0709/11506773/76895243711d/diagnostics-14-02305-g004.jpg

相似文献

1
Visceral Obesity and Its Association with Severe Coronary Artery Calcification in Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease.内脏肥胖及其与代谢功能障碍相关脂肪性肝病患者严重冠状动脉钙化的关联。
Diagnostics (Basel). 2024 Oct 17;14(20):2305. doi: 10.3390/diagnostics14202305.
2
Comparative associations of MASLD and MAFLD with the presence and severity of coronary artery calcification.非酒精性脂肪性肝病(MASLD)和代谢功能障碍相关脂肪性肝病(MAFLD)与冠状动脉钙化的存在及严重程度的比较关联
Res Sq. 2024 Mar 5:rs.3.rs-3979461. doi: 10.21203/rs.3.rs-3979461/v1.
3
Comparative associations of MASLD and MAFLD with the presence and severity of coronary artery calcification.非酒精性脂肪性肝炎(MASLD)和代谢功能障碍相关脂肪性肝病(MAFLD)与冠状动脉钙化的存在及严重程度的比较性关联。
Sci Rep. 2024 Oct 2;14(1):22917. doi: 10.1038/s41598-024-74287-7.
4
Association of overweight/obesity and overweight/obesity-related metabolic dysfunction-associated steatotic liver disease in young adults with coronary artery calcification later in life.超重/肥胖与超重/肥胖相关代谢功能障碍相关脂肪性肝病在年轻人中与晚年冠状动脉钙化的相关性。
Diabetes Obes Metab. 2024 Sep;26(9):3860-3867. doi: 10.1111/dom.15733. Epub 2024 Jun 27.
5
Associations Between Visceral Fat, Abdominal Muscle, and Coronary Artery Calcification: A Cross-Sectional Analysis of the Multi-Ethnic Study of Atherosclerosis.内脏脂肪、腹肌与冠状动脉钙化之间的关联:动脉粥样硬化多族裔研究的横断面分析
Am J Cardiol. 2024 Apr 15;217:77-85. doi: 10.1016/j.amjcard.2024.02.030. Epub 2024 Mar 1.
6
Increased prevalence of high-risk coronary plaques in metabolic dysfunction associated steatotic liver disease patients: A meta-analysis.代谢功能障碍相关脂肪性肝病患者中高危冠状动脉斑块的患病率增加:一项荟萃分析。
Eur J Clin Invest. 2024 Sep;54(9):e14188. doi: 10.1111/eci.14188. Epub 2024 Feb 23.
7
Association of Nonalcoholic Fatty Liver Disease With Visceral Adiposity but Not Coronary Artery Calcification in the Elderly.非酒精性脂肪肝疾病与老年人体内脏脂肪堆积相关,而与冠状动脉钙化无关。
Clin Gastroenterol Hepatol. 2016 Sep;14(9):1337-1344.e3. doi: 10.1016/j.cgh.2016.01.010. Epub 2016 Jan 25.
8
Fatty liver, abdominal adipose tissue and atherosclerotic calcification in African Americans: the Jackson Heart Study.非裔美国人的脂肪肝、腹部脂肪组织和动脉粥样硬化钙化:杰克逊心脏研究。
Atherosclerosis. 2012 Oct;224(2):521-5. doi: 10.1016/j.atherosclerosis.2012.07.042. Epub 2012 Aug 10.
9
Increased visceral adiposity is associated with coronary artery calcification in male patients with chronic kidney disease.内脏脂肪增多与男性慢性肾脏病患者冠状动脉钙化有关。
Eur J Clin Nutr. 2013 Jun;67(6):610-4. doi: 10.1038/ejcn.2013.66. Epub 2013 Mar 27.
10
Visceral adiposity and inflammatory bowel disease.内脏肥胖与炎症性肠病。
Int J Colorectal Dis. 2021 Nov;36(11):2305-2319. doi: 10.1007/s00384-021-03968-w. Epub 2021 Jun 9.

本文引用的文献

1
The Role of Coronary Imaging in Chronic Total Occlusions: Applications and Future Possibilities.冠状动脉成像在慢性完全闭塞病变中的作用:应用与未来可能性
J Cardiovasc Dev Dis. 2024 Sep 21;11(9):295. doi: 10.3390/jcdd11090295.
2
Full-Moon Coronary Calcification as Detected With Computed Tomography Angiography in Chronic Total Occlusion Percutaneous Coronary Intervention.慢性完全闭塞经皮冠状动脉介入治疗中计算机断层血管造影术检测到的满月状冠状动脉钙化。
Am J Cardiol. 2024 Jul 1;222:149-156. doi: 10.1016/j.amjcard.2024.05.008. Epub 2024 May 16.
3
The Clinical Significance of Myosteatosis in Survival Outcomes in Patients with Hepatocellular Carcinoma Treated with Sorafenib.
索拉非尼治疗的肝细胞癌患者中肌少脂变对生存结局的临床意义
Cancers (Basel). 2024 Jan 20;16(2):454. doi: 10.3390/cancers16020454.
4
Metabolic dysfunction-associated steatotic liver disease increases the risk of incident cardiovascular disease: a nationwide cohort study.代谢功能障碍相关脂肪性肝病增加心血管疾病发病风险:一项全国性队列研究
EClinicalMedicine. 2023 Oct 28;65:102292. doi: 10.1016/j.eclinm.2023.102292. eCollection 2023 Nov.
5
A multisociety Delphi consensus statement on new fatty liver disease nomenclature.多学会专家组关于新的脂肪肝疾病命名的德尔菲共识声明。
J Hepatol. 2023 Dec;79(6):1542-1556. doi: 10.1016/j.jhep.2023.06.003. Epub 2023 Jun 24.
6
A multisociety Delphi consensus statement on new fatty liver disease nomenclature.多学会专家共识:新的非酒精性脂肪性肝病命名。
Hepatology. 2023 Dec 1;78(6):1966-1986. doi: 10.1097/HEP.0000000000000520. Epub 2023 Jun 24.
7
When Does a Calcium Score Equate to Secondary Prevention?: Insights From the Multinational CONFIRM Registry.钙评分何时等同于二级预防?来自多国CONFIRM注册研究的见解。
JACC Cardiovasc Imaging. 2023 Sep;16(9):1181-1189. doi: 10.1016/j.jcmg.2023.03.008. Epub 2023 May 24.
8
Management strategies for heavily calcified coronary stenoses: an EAPCI clinical consensus statement in collaboration with the EURO4C-PCR group.重度钙化冠状动脉狭窄的处理策略:EAPCI 与 EURO4C-PCR 协作组联合发布的临床共识声明。
Eur Heart J. 2023 Nov 1;44(41):4340-4356. doi: 10.1093/eurheartj/ehad342.
9
Contemporary issues of percutaneous coronary intervention in heavily calcified chronic total occlusions: an expert review from the European CTO Club.重度钙化慢性完全闭塞病变经皮冠状动脉介入治疗的当代问题:来自欧洲 CTO 俱乐部的专家述评。
EuroIntervention. 2023 Jun 5;19(2):e113-e122. doi: 10.4244/EIJ-D-22-01096.
10
Current utility of the coronary calcium score for the initial evaluation of suspected coronary artery disease.冠状动脉钙化积分在疑似冠状动脉疾病初始评估中的当前应用价值。
Heart. 2023 Apr 12;109(9):659-660. doi: 10.1136/heartjnl-2022-322056.